Medropharm
About Medropharm
Medropharm is a Zurich-based medical cannabis company focused on developing and producing standardized cannabis-based medicines for the Swiss and European markets. The company cultivates cannabis under pharmaceutical conditions and produces a range of medical cannabis products including oils, capsules, and extracts. Medropharm holds Swiss Medic authorization and is one of the leading medical cannabis producers in Switzerland.
Key Facts
- 1One of Switzerland's leading medical cannabis producers
- 2Holds Swiss Medic authorization for cannabis-based medicines
- 3Produces standardized cannabis products with consistent cannabinoid profiles
- 4Based in Zurich with pharmaceutical-grade production facilities
Frequently Asked Questions
How is medical cannabis regulated in Switzerland?
Medical cannabis in Switzerland requires authorization from Swiss Medic (the Swiss medicines regulator) and the Federal Office of Public Health. Since 2022, doctors can prescribe medical cannabis directly without special BAG authorization, improving patient access.
What products does Medropharm offer?
Medropharm produces a range of standardized medical cannabis products including oils with defined THC/CBD ratios, cannabis extracts, and capsules, all manufactured under pharmaceutical conditions.
More Cannabis Companies in Zurich
Cannabis Laws
Products
- Medical cannabis oils
- Standardized cannabis extracts
- Cannabis capsules and preparations
Specialties
Company Details
- Type
- Medical & Pharma
- Location
- Zurich, Switzerland
- Founded
- 2014
- Publicly Traded
- No